Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (4) , 508-514
- https://doi.org/10.1016/j.ejca.2003.10.022
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Capecitabine as first-line treatment in colorectal cancerEuropean Journal Of Cancer, 2002
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- Phase I and pharmacokinetic study of irinotecan (CPT-11) given by 24 hours infusion plus oral uracil/tegafur (UFT) in patients with lung cancerEuropean Journal Of Cancer, 1999
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerThe Lancet, 1998
- CPT-11.Annals of the New York Academy of Sciences, 1996
- Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedulesAnti-Cancer Drugs, 1996
- Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II studyEuropean Journal Of Cancer, 1995
- CPT-11 (Irinotecan) in the treatment of colorectal cancerEuropean Journal Of Cancer, 1995
- Topoisomerase I inhibitors: topotecan and irenotecanCancer Treatment Reviews, 1994